Skip to main content
Log in

Adverse Drug Reaction Update

  • Around the Journals
  • Published:
Adverse Drug Reactions and Toxicological Reviews

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. 1 Reactions Weekly is the complete drug safety alerting service and summarises information selected from over 1600 biomedical journals. This newsletter is produced by Adis International and is available in a variety of formats. Please contact your nearest Adis office for subscription details.

  2. * Diazepam, chlordiazepoxide, clonazepam, lorazepam and alprazolam.

  3. * The views expressed are those of the authors and do not necessarily represent those of, nor imply endorsement by, the FDA or the US government.

  4. * Taken at a median of 4 hours after admission to hospital.

  5. ** Taken at a median of 12 hours after admission to hospital.

References

  • Aceti A, Pasquazzi C, Zechini B, et al. Hepatotoxicity development during antiretroviral therapy containing protease inhibitors in patients with HIV. The role of hepatitis B and C virus infection. J Acq Immune Defic Syndr 2002 Jan; 29: 41–8

    CAS  Google Scholar 

Reference

  • Feenstra J, Heerdink ER, Grobbee DE, et al. Association of non-steroidal anti-inflammatory drugs with first occurrence of heart failure and with relapsing heart failure: the Rotterdam Study. Arch Intern Med 2002 Feb 11; 162: 265–70

    Article  PubMed  CAS  Google Scholar 

Reference

  • Iqbal MM, Sobhan T, Ryals T. Effects of commonly used benzodiazepines on the fetus, the neonate, and the nursing infant. Psychiatric Services 2002 Jan; 53: 39–49

    Article  PubMed  Google Scholar 

Reference

  • Ray WA, Meredith S, Thapa PB, et al. Antipsychotics and the risk of sudden cardiac death. Arch Gen Psychiatry 2001 Dec; 58: 1161–7

    Article  PubMed  CAS  Google Scholar 

Reference

  • Schillevoort I, van Puijenbroek EP, de Boer A, et al. Extrapyramidal syndromes associated with selective serotonin reuptake inhibitors: a case-control study using spontaneous reports. Int Clin Psychopharmacol 2002 Mar; 17: 75–9

    Article  PubMed  CAS  Google Scholar 

References

  1. Walker-Smith J. Autism, bowel inflammation, and measles. Lancet 2002 Feb; 359: 705–6

    Article  PubMed  Google Scholar 

  2. Lancet. Time to look beyond MMR in autism research. Lancet 2002 Feb; 359: 637

Reference

  • Hobson DE, Lang AE, Martin WRW, et al. Excessive daytime sleepiness and sudden-onset sleep in Parkinson disease: a survey by the Canadian Movement Disorders Group. JAMA 2002 Jan; 287: 455–63

    Article  PubMed  Google Scholar 

Reference

  • Staffa JA, Chang J, Green L. Cerivastatin and reports of fatal rhabdomyolysis. N Engl J Med 2002 Feb; 346: 539–40

    Article  PubMed  Google Scholar 

Reference

  • Bernal W, Donaldson N, Wyncoll D, et al. Blood lactate as an early predictor of outcome in paracetamol-induced acute liver failure: a cohort study. Lancet 2002 Feb; 359: 558–63

    Article  PubMed  CAS  Google Scholar 

Reference

  • Lilly CM, Churg A, Lazarovich M, et al. Asthma therapies and Churg-Strauss syndrome. J Allergy Clin Immunol 2002 Jan; 109: 1–20

    Article  Google Scholar 

Reference

  • Côté HCF, Brumme ZL, Craib KJP, et al. Changes in mitochondrial DNA as a marker of nucleoside toxicity in HIV-infected patients. N Engl J Med 2002 Mar; 346: 811–20

    Article  PubMed  Google Scholar 

Reference

  • Seidman A, Hudis C, Pierri MK, et al. Cardiac dysfunction in the trastuzumab clinical trials experience. J Clin Oncol 2002; 20: 1215–21

    Article  PubMed  CAS  Google Scholar 

References

  1. Klip H, Verloop J, van Gool JD, et al. Hypospadias in sons of women exposed to diethylstilbestrol in utero: a cohort study. Lancet 2002 Mar; 359: 1102–7

    Article  PubMed  CAS  Google Scholar 

  2. Hernndez-Daz S. Iatrogenic legacy from diethylstilbestrol exposure. Lancet 2002 Mar; 359: 1081–2

    Article  Google Scholar 

Reference

  • Nathan PD, Gore ME, Eisen TG. Unexpected toxicity of combination thalidomide and interferon alfa-2a treatment in metastatic renal cell carcinoma. J Clin Oncol 2002 Mar; 20: 1429–30

    PubMed  CAS  Google Scholar 

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adverse Drug Reaction Update. Adv Drug React Toxicol Rev 21, 113–120 (2002). https://doi.org/10.1007/BF03256186

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03256186

Navigation